These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12717951)

  • 1. [Hospital infection due to drug-resistant Pseudomonas aeruginosa].
    Hirakata Y
    Nihon Rinsho; 2003 Mar; 61 Suppl 3():84-9. PubMed ID: 12717951
    [No Abstract]   [Full Text] [Related]  

  • 2. Emergence of metallo-β-lactamases GIM-1 and VIM in multidrug-resistant Pseudomonas aeruginosa in North Rhine-Westphalia, Germany.
    Rieber H; Frontzek A; von Baum H; Pfeifer Y
    J Antimicrob Chemother; 2012 Apr; 67(4):1043-5. PubMed ID: 22247491
    [No Abstract]   [Full Text] [Related]  

  • 3. Control of an outbreak of carbapenem-resistant Pseudomonas aeruginosa in a haemato-oncology unit.
    Nagao M; Iinuma Y; Igawa J; Saito T; Yamashita K; Kondo T; Matsushima A; Takakura S; Takaori-Kondo A; Ichiyama S
    J Hosp Infect; 2011 Sep; 79(1):49-53. PubMed ID: 21722990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Impact of dissemination of metallo-beta-lactamase-producing multidrug-resistant Pseudomonas aeruginosa in hospitals: present and future].
    Oliver A
    Enferm Infecc Microbiol Clin; 2009 May; 27(5):255-6. PubMed ID: 19361889
    [No Abstract]   [Full Text] [Related]  

  • 5. IMP-4-producing Pseudomonas aeruginosa in a French patient repatriated from Malaysia: impact of early detection and control measures.
    Bert F; Vanjak D; Leflon-Guibout V; Mrejen S; Delpierre S; Redondo A; Nicolas-Chanoine MH
    Clin Infect Dis; 2007 Mar; 44(5):764-5. PubMed ID: 17278079
    [No Abstract]   [Full Text] [Related]  

  • 6. Detection of blaVIM-2 carbapenemase in Pseudomonas aeruginosa in Ireland.
    Walsh F; Rogers TR
    J Antimicrob Chemother; 2008 Jan; 61(1):219-20. PubMed ID: 18024489
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pseudomonas aeruginosa].
    Ono Y
    Nihon Rinsho; 2002 Nov; 60(11):2150-5. PubMed ID: 12440121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-lactamase producing Pseudomonas aeruginosa in hospitalised patients.
    Pandey A; Malenie R; Asthana AK
    Indian J Pathol Microbiol; 2005 Oct; 48(4):530-3. PubMed ID: 16366119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phenotypic and genotypic characterization of imipenem-resistant Pseudomonas aeruginosa isolated in a Buenos Aires hospital].
    Cejas D; Almuzara M; Santella G; Tuduri A; Palombarani S; Figueroa S; Gutkind G; Radice M
    Rev Argent Microbiol; 2008; 40(4):238-45. PubMed ID: 19213249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Infection control and prevention for multiple drug resistant pseudomonas aeruginosa].
    Maesaki S
    Nihon Geka Gakkai Zasshi; 2007 Sep; 108(5):274-8. PubMed ID: 17907458
    [No Abstract]   [Full Text] [Related]  

  • 11. [Importance of appropriate carbapenem use to reduce carbapenem--resistant Pseudomonas aeruginosa].
    Furukawa K
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():258-64. PubMed ID: 17455627
    [No Abstract]   [Full Text] [Related]  

  • 12. [Molecular characterization of carbapenemases in Pseudomonas aeruginosa infection. Clinical study in three oncological patients].
    García-Lozano T; Aznar E; Lorente P; Gimeno C
    Med Clin (Barc); 2011 Dec; 137(15):709-10. PubMed ID: 21514940
    [No Abstract]   [Full Text] [Related]  

  • 13. Isolation and characterization of an imported extremely-resistant Pseudomonas aeruginosa producing three different extended-spectrum β-lactamases and hyperproducing two multidrug-efflux pumps.
    Ratkai C; Nagy E; Peixe L; Bertalan V; Hajdú E
    J Infect; 2010 Dec; 61(6):511-2. PubMed ID: 20951729
    [No Abstract]   [Full Text] [Related]  

  • 14. Emerging resistant Gram-negative aerobic bacilli in hospital-acquired infections.
    Kunz AN; Brook I
    Chemotherapy; 2010; 56(6):492-500. PubMed ID: 21099222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clusters of infection due to metallo-β-lactamase-producing Pseudomonas aeruginosa in stem cell transplant and haematology units.
    Paez J; Levin AS; Fu L; Basso M; Fonseca GH; Dulley FL; Rossi F; Guimarães T; Costa SF
    J Hosp Infect; 2011 Jan; 77(1):76-7. PubMed ID: 21030111
    [No Abstract]   [Full Text] [Related]  

  • 16. Carbapenemase-producing Pseudomonas aeruginosa and ciprofloxcacin use in neonatal intensive care units.
    Toraman ZA; Yakupogullari Y
    J Hosp Infect; 2003 Jun; 54(2):164-5. PubMed ID: 12818594
    [No Abstract]   [Full Text] [Related]  

  • 17. [Resistance caused by hyperproduction of chromosomal beta-lactamase in Pseudomonas aeruginosa].
    Tirado M; Hermida M; Reig R; Esteva C; Vidal R; Roy C
    Enferm Infecc Microbiol Clin; 1989 Dec; 7(10):530-4. PubMed ID: 2518765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug-resistant Pseudomonas aeruginosa isolate co-expressing extended-spectrum beta-lactamase PER-1 and metallo-beta-lactamase VIM-2 from Turkey.
    Yakupogullari Y; Poirel L; Bernabeu S; Kizirgil A; Nordmann P
    J Antimicrob Chemother; 2008 Jan; 61(1):221-2. PubMed ID: 17981831
    [No Abstract]   [Full Text] [Related]  

  • 19. Superbugs in the coming new decade; multidrug resistance and prospects for treatment of Staphylococcus aureus, Enterococcus spp. and Pseudomonas aeruginosa in 2010.
    Nordmann P; Naas T; Fortineau N; Poirel L
    Curr Opin Microbiol; 2007 Oct; 10(5):436-40. PubMed ID: 17765004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial therapy and control of multidrug-resistant Pseudomonas aeruginosa bacteremia in a teaching hospital in Taiwan.
    Leung CH; Wang NY; Liu CP; Weng LC; Hsieh FC; Lee CM
    J Microbiol Immunol Infect; 2008 Dec; 41(6):491-8. PubMed ID: 19255693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.